Novartis (NVS) Inks Deal for ARVN's Prostate Cancer Candidate

Published on 12 Apr 2024 on Zacks via Yahoo Finance

Novartis (NVS) Inks Deal for ARVN's Prostate Cancer Candidate

Novartis NVS entered into an exclusive strategic license agreement with a clinical-stage biotechnology company, Arvinas, Inc. ARVN, for the worldwide development and commercialization of the latter’s pipeline candidate ARV-766. Shares of ARVN were up on the news.

The deal also includes an asset purchase agreement for the sale of Arvinas’ preclinical AR-V7 program to Novartis.

Read the rest of the article

NASDAQ.ARVN price evolution

NYSE.NVS price evolution

SIX.NOVN price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Richemont’s Market Cap Surpasses CHF100 Billion

Swiss luxury conglomerate Richemont’s stock market value surpassed 100 billion Swiss francs ($110...

The Business of Fashion 23 Jan 2025

Trump’s Tariff Shifts Are a Warning for Corporate America to Expect Whiplash

(Bloomberg) -- Donald Trump opened his second term as US president with a market-jolting...

Bloomberg · via Yahoo News 21 Jan 2025

Outlook Therapeutics Vision Loss Drug At Par With Novartis Drug

ONS-5010 demonstrated non-inferiority to Novartis AG (NYSE:NVS) / Roche Holdings AG’s (OTC:RHHBY)...

Benzinga · via Yahoo Finance 16 Jan 2025

Is WisdomTree International Equity ETF (DWM) a Strong ETF Right Now?

And, most ETFs are very transparent products that disclose their holdings on a daily basis. Looki...

Zacks · via Yahoo Finance 16 Jan 2025

Novartis’ Gene Therapy Shows Promise in Treating SMA

Novartis ( (NVS) ) has provided an update. Novartis announced the success of its Phase III STEER ...

TipRanks · via Yahoo Finance 31 Dec 2024

Why Is Novartis AG (NVS) Among the Best European Dividend Stocks To Buy Now?

We recently compiled a list of the 10 Best European Dividend Stocks To Buy. In this article, we a...

Insider Monkey · via Yahoo Finance 23 Dec 2024

European Health Stocks Brace for Year Clouded by US Politics

(Bloomberg) -- After falling off their perch in the last few months of 2024, European healthcare...

Bloomberg · via Yahoo Finance 19 Dec 2024

Novartis AG (NVS): Among the Oversold Global Stocks to Buy Right Now

We recently compiled a list of the 10 Oversold Global Stocks To Buy Right Now. In this article, w...

Insider Monkey · via Yahoo Finance 18 Dec 2024

3 Biotech Stocks With Promising Gene Therapies to Watch Out in 2025

Voyager Therapeutics, Inc. price-consensus-chart | Voyager Therapeutics, Inc. Quote VYGR also...

Zacks · via Yahoo Finance 18 Dec 2024

Is Vanguard International Dividend Appreciation ETF (VIGI) a Strong ETF Right...

Luckily, most ETFs are very... (SAP) accounts for about 4.54% of the fund's total assets, followe...

Zacks · via Yahoo Finance 5 Dec 2024